REYGLOFI
Live / Applied — Second extension granted (statement of use) (as of 06 Jan 2026)
What this means for you
Not registered yet, but its 21 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97901522
- Mark type
- Stylized text
- Filed
- 21 Apr 2023
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neurological diseases and disorders
Owner
- Chimerix, Inc., Durham, NC, US
- Chimerix, Inc., Durham, NC, US
Prosecution history
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2026 — SOU EXTENSION 2 GRANTED
- 06 Jan 2026 — SOU EXTENSION 2 FILED
- 06 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2025 — SOU EXTENSION 1 GRANTED
- 03 Jul 2025 — SOU EXTENSION 1 FILED
- 03 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE